Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000329408 | SCV000759923 | benign | Kleefstra syndrome 1 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706611 | SCV001836609 | benign | not provided | 2019-11-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706611 | SCV002546134 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | EHMT1: BP4, BP7 |
Ambry Genetics | RCV002348121 | SCV002619398 | likely benign | Inborn genetic diseases | 2017-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |